pioglitazone has been researched along with dinoprostone in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (50.00) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Hase, T; Kawahito, Y; Mitsuhashi, M; Nakatani, T; Sano, H; Segawa, Y; Wada, S; Yoshimura, R | 1 |
Goto, J; Hiratsuka, M; Hishinuma, T; Mizugaki, M; Suzuki, N; Tayama, R; Tsukamoto, H; Yoshihisa, T | 1 |
Brzozowski, T; Burnat, G; Cieszkowski, J; Hahn, EG; Konturek, PC; Konturek, S; Kwiecień, SN; Pajdo, R; Pawlik, WW; Targosz, A | 1 |
Batra, RK; Cui, X; Dubinett, SM; Hazra, S; Sharma, S; Tai, HH | 1 |
Hasegawa, K; Hayashi, K; Homma, K; Ito, O; Kanda, T; Omata, K; Saruta, T; Sugano, N; Tatematsu, S; Wakino, S; Yoshioka, K | 1 |
Carranza, A; Mayer, MA; Peredo, HA; Puyó, AM | 1 |
Cook, JL; Hanks, BC; Kuroki, K; Stoker, AM | 1 |
Dannenberg, AJ; Howe, LR; Hudis, CA; Kopelovich, L; Subbaramaiah, K; Yang, P; Zhou, XK | 1 |
Dubois, RN; Margalit, O; Wang, D | 1 |
Chan, DC; Chao, SC; Chen, CM; Chen, YJ; Lan, KC; Liu, SH; Tsai, KS; Wang, CC; Yang, RS | 1 |
Hashemitabar, M; Hemmati, AA; Houshmand, G; Mansouri, MT; Naghizadeh, B | 1 |
12 other study(ies) available for pioglitazone and dinoprostone
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Chromans; Dinoprostone; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Humans; Immunohistochemistry; Ligands; Male; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Testicular Neoplasms; Testis; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2002 |
Thiazolidinediones increase arachidonic acid release and subsequent prostanoid production in a peroxisome proliferator-activated receptor gamma-independent manner.
Topics: Animals; Arachidonic Acid; Cell Membrane; Chlorocebus aethiops; COS Cells; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Humans; Lipopolysaccharides; Membrane Proteins; Mice; NIH 3T3 Cells; Phospholipases A; Phosphorylation; Pioglitazone; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Rosiglitazone; Thiazolidinediones; Thromboxane A2; U937 Cells | 2004 |
Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties.
Topics: Animals; Anti-Ulcer Agents; Blood Flow Velocity; Blotting, Western; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Gastric Mucosa; Gene Expression; Indomethacin; Interleukin-1; Male; Nitric Oxide Synthase; Nitroarginine; Pioglitazone; Platelet Endothelial Cell Adhesion Molecule-1; PPAR gamma; Rats; Rats, Wistar; Restraint, Physical; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Ulcer; Thiazolidinediones; Tumor Necrosis Factor-alpha; Wound Healing | 2005 |
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
Topics: Carcinoma, Non-Small-Cell Lung; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Humans; Hydroxyprostaglandin Dehydrogenases; Hypoglycemic Agents; Membrane Proteins; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2007 |
Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats.
Topics: Animals; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dinoprostone; Disease Models, Animal; Edema; Epithelial Sodium Channels; Female; Fenofibrate; Hypoglycemic Agents; Hypolipidemic Agents; Kidney; Ligands; Male; Natriuresis; Nitric Oxide Synthase; Obesity; Ovariectomy; Pioglitazone; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Zucker; Sodium; Thiazolidinediones | 2008 |
Pioglitazone and losartan modify hemodynamic and metabolic parameters and vascular prostanoids in fructose-overloaded rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Blood Vessels; Dinoprostone; Drug Synergism; Epoprostenol; Fructose; Hemodynamics; In Vitro Techniques; Losartan; Male; Mesentery; Pioglitazone; PPAR gamma; Prostaglandins; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thromboxanes; Triglycerides | 2008 |
Evaluation of anti-inflammatory and chondroprotective effects of peroxisome proliferator-activated receptor gamma agonists in cartilage and synovial explants from dogs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cartilage; Coculture Techniques; Dinoprostone; Dogs; Interleukin-1beta; Nitric Oxide; Pioglitazone; PPAR gamma; Prostaglandin D2; Synovial Membrane; Thiazolidinediones; Time Factors | 2010 |
Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.
Topics: Adipose Tissue; Animals; Aromatase; Blotting, Western; BRCA1 Protein; Breast Neoplasms; Cells, Cultured; Chromatin Immunoprecipitation; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Electrophoretic Mobility Shift Assay; Female; Gene Expression Regulation, Enzymologic; Humans; Hydroxyprostaglandin Dehydrogenases; Hypoglycemic Agents; Mice; Pioglitazone; PPAR gamma; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Snail Family Transcription Factors; Thiazolidinediones; Transcription Factors | 2012 |
PPARγ agonists target aromatase via both PGE2 and BRCA1.
Topics: Aromatase; BRCA1 Protein; Breast Neoplasms; Dinoprostone; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Hypoglycemic Agents; Pioglitazone; PPAR gamma; Thiazolidinediones | 2012 |
PPARγ is involved in the hyperglycemia-induced inflammatory responses and collagen degradation in human chondrocytes and diabetic mouse cartilages.
Topics: Adult; Aged; Animals; Cartilage; Chondrocytes; Collagen; Diabetes Mellitus, Experimental; Dinoprostone; Humans; Hyperglycemia; Inflammation; Male; Matrix Metalloproteinase 13; Mice; Mice, Inbred ICR; Middle Aged; Pioglitazone; PPAR gamma; Streptozocin; Thiazolidinediones | 2015 |
Potentiation of indomethacin-induced anti-inflammatory response by pioglitazone in carrageenan-induced acute inflammation in rats: Role of PPARγ receptors.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Drug Therapy, Combination; Edema; Indomethacin; Inflammation; Interleukin-10; Male; Pioglitazone; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2016 |